Sr. Manager, Strategic Options & Assessment - Hematology, Oncology, Cell Therapy

Role: Senior Manager in Strategic Options and Assessment (SOA) supporting global programs in hematology, oncology, and cell therapy, focusing on value-driven decision-making and risk analysis. Responsibilities: apply therapeutic area expertise and financial modeling to guide high-quality investment decisions; facilitate strategic workshops; develop decision analysis tools; track project progress; and collaborate with cross-functional stakeholders to prioritize portfolio options. Qualifications: bachelor's degree in science, engineering, economics, or related quantitative field; at least 5 years of experience in financial analysis, modeling, or valuation; and familiarity with drug development processes. Preferred: knowledge of clinical and regulatory stages specific to hematology, oncology, or cell therapy; experience in decision science or management science; comfort managing matrix stakeholder relationships and navigating ambiguity. High-value details: supporting decision-making at opportunity and asset levels, emphasizing risk assessment, valuation, and portfolio prioritization within biopharma R&D; involvement in strategic frameworks for pipeline maximization. Work setup: roles may be site-essential, hybrid, or remote, with travel as needed for collaboration. The position is embedded within a broader team supporting enterprise-wide pipeline and portfolio decisions, directly influencing investment and development strategies.